SOURCE: Dynavax Technologies

Dynavax Technologies

February 19, 2015 16:15 ET

Dynavax to Present at the 2015 RBC Capital Markets' Global Healthcare Conference

BERKELEY, CA--(Marketwired - Feb 19, 2015) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Eddie Grey, the Company's Chief Executive Officer, will present at the 2015 RBC Capital Markets' Global Healthcare Conference on Tuesday, February 24, 2015 at 9:30 AM Eastern Time at the New York Palace Hotel in New York City.

A live webcast of the presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at: http://www.veracast.com/webcasts/rbc/healthcare2015/74104424775.cfm.

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidate is HEPLISAV-B, a Phase 3 investigational adult hepatitis B vaccine. For more information visit www.dynavax.com.

Contact Information

  • Contact:
    Michael Ostrach
    Chief Business and Principal Financial Officer
    510-665-7257
    Email Contact